Please note that our note on 14th December regarding RUA’s conditional Placing and Open Offer used an incorrect share count, now amended in this version. Our valuation of the company, assuming a full raise of £7m, is unchanged from the earlier note at £115.2m but the fair value per share is adjusted to reflect new share issuance. Upon completion of the issues, RUA will have the resources to accelerate the development of its products, on which much of our valuation has been based.
16 Dec 2020
Christmas comes early - Fundraising and Interims
Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
Christmas comes early - Fundraising and Interims
RUA Life Sciences Plc (RUA:LON) | 11.0 -0.1 (-4.3%) | Mkt Cap: 6.83m
- Published:
16 Dec 2020 -
Author:
Hannah Crowe | Andy Smith -
Pages:
5
Please note that our note on 14th December regarding RUA’s conditional Placing and Open Offer used an incorrect share count, now amended in this version. Our valuation of the company, assuming a full raise of £7m, is unchanged from the earlier note at £115.2m but the fair value per share is adjusted to reflect new share issuance. Upon completion of the issues, RUA will have the resources to accelerate the development of its products, on which much of our valuation has been based.